It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local ...

Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...

DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...

AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...

Compare the Apple Watch, Samsung Galaxy Watch, and Pixel Watch for blood sugar tracking, CGM alerts, health trends, battery ...

Continuous glucose monitors have become popular among those who need to track their glucose levels because they're painless ...

President and CEO Jake Leach said, “Glucose matters for everyone.” The company plans to broaden access to glucose biosensing ...

Teleflex reported 2025 compensation for top executives, including two who left after the medtech CDMO sold off some big ...

Italy will be out for Women's Rugby World Cup revenge against South Africa when they host the southern hemisphere side in the ...

Dexcom has reported the 2025 pay packages for executives including former CEO Kevin Sayer and new CEO Jake Leach, who was promoted twice last year and unexpectedly stepped into the top spot ahead of ...

Every day there are new posts in a Facebook group — 89.5 thousand members strong — dedicated to Dexcom G7 issues and complaints. From inaccurate CGM readings and sensor failures to frustrating ...

June 6 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not ...